Pomdoctor appeals Nasdaq delisting notice after ADSs trade below $1 bid price threshold

Bitget2026/10/09 20:05

Pomdoctor received a Nasdaq delisting determination letter on Oct. 6, 2026, tied to its ADS bid price staying below $1.00 for 30 sessions. Trading suspension is set for the open on Oct. 15, 2026, unless an appeal is filed; Nasdaq would then move to remove the listing. A prior 1-for-18 reverse stock split on June 22, 2026 left the company without a standard cure period. Management plans to request a Nasdaq hearings panel review by Oct. 13, 2026, submitting a plan to regain the minimum bid price. A timely hearing request would pause the suspension while the panel reviews the appeal. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610091605PR_NEWS_USPR_____CN67655) on October 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

United States Dollar Index remains subdued as lower oil prices ease inflation pressure

FXStreet•2026/11/09 04:54

Citi is bullish on the Indian stock market, expecting the Nifty Index to rise to 28,000 points by the end of 2027.

路透社•2026/11/09 04:06

Silver Price Forecast: XAG/USD rises to near $53.00 as lower oil eases inflation pressure

FXStreet•2026/11/09 03:39

JPMorgan lowers the target price of Sociedad Química y Minera de Chile to $71

格隆汇•2026/11/09 03:11